methotrexate has been researched along with Leishmaniasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, CL; Huggan, JK; Hunter, WN; Iulek, J; Lee, JH; Martini, VP; Smith, TK; Suckling, CJ; Tulloch, LB | 1 |
| Beverley, S; Hardy, LW; Luba, J; Nare, B | 1 |
| Arora, SK; Basu, SK; Chaudhuri, G; Mukhopadhyay, A; Sehgal, S | 1 |
1 review(s) available for methotrexate and Leishmaniasis
| Article | Year |
|---|---|
New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Topics: Animals; Drug Resistance; Folic Acid Antagonists; Leishmania; Leishmaniasis; Methotrexate; Oxidoreductases; Pteridines | 1997 |
2 other study(ies) available for methotrexate and Leishmaniasis
| Article | Year |
|---|---|
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Leishmania major; Leishmaniasis; Models, Molecular; Molecular Structure; Oxidoreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |
Receptor-mediated drug delivery to macrophages in chemotherapy of leishmaniasis.
Topics: Albumins; Animals; Cells, Cultured; Cricetinae; Female; Kinetics; Leishmania mexicana; Leishmaniasis; Macrophages; Male; Membrane Proteins; Mesocricetus; Methotrexate; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Serum Albumin, Bovine | 1989 |